JP2022545916A5 - - Google Patents

Info

Publication number
JP2022545916A5
JP2022545916A5 JP2022513150A JP2022513150A JP2022545916A5 JP 2022545916 A5 JP2022545916 A5 JP 2022545916A5 JP 2022513150 A JP2022513150 A JP 2022513150A JP 2022513150 A JP2022513150 A JP 2022513150A JP 2022545916 A5 JP2022545916 A5 JP 2022545916A5
Authority
JP
Japan
Prior art keywords
compound
trp
sar
peg3
analogy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022513150A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022545916A (ja
JP7711044B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/073905 external-priority patent/WO2021037942A1/en
Publication of JP2022545916A publication Critical patent/JP2022545916A/ja
Publication of JP2022545916A5 publication Critical patent/JP2022545916A5/ja
Application granted granted Critical
Publication of JP7711044B2 publication Critical patent/JP7711044B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022513150A 2019-08-27 2020-08-26 コンプスタチン類似体及びその医学的使用 Active JP7711044B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19193925.5 2019-08-27
EP19193925 2019-08-27
EP20172189.1 2020-04-29
EP20172189 2020-04-29
PCT/EP2020/073905 WO2021037942A1 (en) 2019-08-27 2020-08-26 Compstatin analogues and their medical uses

Publications (3)

Publication Number Publication Date
JP2022545916A JP2022545916A (ja) 2022-11-01
JP2022545916A5 true JP2022545916A5 (cg-RX-API-DMAC10.html) 2023-09-04
JP7711044B2 JP7711044B2 (ja) 2025-07-22

Family

ID=72178552

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022513150A Active JP7711044B2 (ja) 2019-08-27 2020-08-26 コンプスタチン類似体及びその医学的使用

Country Status (14)

Country Link
US (1) US20220306695A1 (cg-RX-API-DMAC10.html)
EP (2) EP4272751B1 (cg-RX-API-DMAC10.html)
JP (1) JP7711044B2 (cg-RX-API-DMAC10.html)
KR (1) KR20220066287A (cg-RX-API-DMAC10.html)
CN (1) CN114630836A (cg-RX-API-DMAC10.html)
AU (1) AU2020338688B2 (cg-RX-API-DMAC10.html)
BR (1) BR112022003760A2 (cg-RX-API-DMAC10.html)
CA (1) CA3148536A1 (cg-RX-API-DMAC10.html)
CO (1) CO2022003556A2 (cg-RX-API-DMAC10.html)
ES (1) ES3049784T3 (cg-RX-API-DMAC10.html)
IL (1) IL290858A (cg-RX-API-DMAC10.html)
MX (1) MX2022002433A (cg-RX-API-DMAC10.html)
TW (1) TW202128731A (cg-RX-API-DMAC10.html)
WO (1) WO2021037942A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020017385A2 (pt) * 2018-02-27 2020-12-15 Zp Spv 3 K/S Análogos de compstatina, métodos e seus usos médicos
JP2023538807A (ja) * 2020-07-16 2023-09-12 セッドぺー エスぺーヴェー 3 カー/エス 補体因子c3の阻害剤及びそれらの医学的使用
KR20240118914A (ko) 2021-01-20 2024-08-05 바이킹 테라퓨틱스 인코포레이티드 대사 및 간 질환 치료를 위한 조성물 및 방법
CA3231953A1 (en) 2021-09-15 2023-03-23 Brian Lian Compositions and methods for the treatment of metabolic and liver disorders
WO2023048151A1 (ja) * 2021-09-22 2023-03-30 塩野義製薬株式会社 ウイルス増殖阻害活性を有する環状ペプチド
EP4622992A1 (en) * 2022-11-24 2025-10-01 Amyndas Pharmaceuticals US LLC Compstatin analogs for vector-based therapy
WO2026112532A1 (en) * 2024-11-22 2026-05-28 Apellis Pharmaceuticals, Inc. Compstatin analogs
US20260234189A1 (en) 2025-01-24 2026-08-13 Boehringer Ingelheim International Gmbh Novel and stable compstatin analogues

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000505068A (ja) 1996-03-13 2000-04-25 トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア 補体活性化を阻害する新規ペプチド類
DE122009000079I2 (de) 1996-08-30 2011-06-16 Novo Nordisk As Novo Alle Glp-1 derivate
CZ295838B6 (cs) 1996-09-09 2005-11-16 Zealand Pharma A/S Způsob výroby peptidů
WO1999013899A1 (en) * 1997-09-17 1999-03-25 Trustees Of The University Of Pennsylvania Peptides and peptidomimetics for inhibiting complement activation
US6451987B1 (en) 1999-03-15 2002-09-17 Novo Nordisk A/S Ion exchange chromatography of proteins and peptides
CA2361830A1 (en) 1999-03-17 2000-09-21 Novo Nordisk A/S Method for acylating peptides and novel acylating agents
US7989589B2 (en) 2002-09-20 2011-08-02 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved activity
CN101325963B (zh) 2005-10-08 2016-01-27 博泰迪亚制药公司 用于眼部病症的补体抑制素和其类似物
ES2390828T3 (es) 2005-11-28 2012-11-16 The Trustees Of The University Of Pennsylvania Análogos potentes de la compstatina
WO2008153963A1 (en) 2007-06-08 2008-12-18 The Trustees Of The University Of Pennsylvania Structure of compstatin-c3 complex and use for rational drug design
WO2010039690A1 (en) * 2008-09-30 2010-04-08 The Trustees Of The University Of Pennsylvania Method of inhibiting biomaterial-induced procoagulant activity using complement inhibitors
CA2813049A1 (en) * 2010-09-23 2012-03-29 The Trustees Of The University Of Pennsylvania Modified compstatin with improved stability and binding properties
PL2753636T3 (pl) 2011-09-07 2020-05-18 The Trustees Of The University Of Pennsylvania Analogi kompstatyny o ulepszonych właściwościach farmakokinetycznych
WO2014100407A1 (en) * 2012-12-19 2014-06-26 The Regents Of The University Of California Compstatin analogs
AR099569A1 (es) * 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
US20180057538A1 (en) * 2016-08-26 2018-03-01 The Regents Of The University Of California Potent and highly soluble pegylated compstatin peptides
BR112020017385A2 (pt) * 2018-02-27 2020-12-15 Zp Spv 3 K/S Análogos de compstatina, métodos e seus usos médicos

Similar Documents

Publication Publication Date Title
RU2020128624A (ru) Аналоги компстатина и их медицинское применение
JP6185920B2 (ja) ポリミキシン誘導体
RU2428429C2 (ru) Пептидные антибиотики и способы их получения
EP2894160B1 (en) Compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof
ES2292558T3 (es) Kahalalido f y compuestos relacionados.
JP2023538807A5 (cg-RX-API-DMAC10.html)
JPS6351159B2 (cg-RX-API-DMAC10.html)
CN101693736A (zh) 新的肽
US5386011A (en) Hexapeptide anaphylatoxin-receptor ligands
JP2009532384A5 (cg-RX-API-DMAC10.html)
JPS60156700A (ja) トリペプチド化合物、その製造法および医薬組成物
PT100563A (pt) Ligandos tri-tetra- e pentapeptidicos do receptor da anafilatoxina, terminalmente modificados, composicoes farmaceuticas e uso
JP2011517675A (ja) Gh−rhの新規なn−およびc−末端が置換されたアンタゴニスト類似体
DE69528531T2 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
US5223485A (en) Anaphylatoxin-receptor ligands
PL165133B1 (pl) Sposób wytwarzania nowych peptydów PL PL PL PL PL PL
EP2010203A2 (en) Macrocyclic peptides and methods for making and using them
CA2127330C (en) Motilin-like polypeptides with gastrointestinal motor stimulating activity
JPH04501259A (ja) Crf拮抗体
HUT75538A (en) Oligopeptides derived from c-reactive protein fragments
AU718320B2 (en) Peptide derivatives
HU229220B1 (hu) Humán növekedési hormont felszabadító hormon-analógok
JPH07509714A (ja) ペプチド肺表面活性剤及び治療用組合せ
WO2014191392A1 (en) New cationic amino acids, pharmaceutical compositions containing the same and their use for the treatment of bacterial infections
JP2627262B2 (ja) 新規トリペプチド化合物